Literature DB >> 31044615

Assessment of the response of hepatocellular carcinoma to interventional radiology treatments.

Francesca Patella1,2, Filippo Pesapane1,2, Enrico Fumarola1,2, Stefania Zannoni1, Pietro Brambillasca1, Ilaria Emili1, Guido Costa3, Victoria Anderson2, Elliot B Levy2, Gianpaolo Carrafiello1, Bradford J Wood2.   

Abstract

According to Barcelona Clinic Liver Cancer (BCLC) guidelines, interventional radiology procedures are valuable treatment options for many hepatocellular carcinomas (HCCs) that are not amenable to resection or transplantation. Accurate assessment of the efficacy of therapies at earlier stages enables completion of treatment, optimal follow-up and to prevent potentially unnecessary treatments, side effects and costly failure. The goal of this review is to summarize and describe the radiological strategies that have been proposed to predict survival and to stratify HCC responses after interventional radiology therapies. New techniques currently in development are also described.

Entities:  

Keywords:  HCC; TACE; imaging; interventional radiology; response criteria

Mesh：

Year:  2019        PMID： 31044615      PMCID： PMC6543503          DOI： 10.2217/fon-2018-0747

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


  70 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

Authors:  Ihab R Kamel; David A Bluemke; John Eng; Eleni Liapi; Wells Messersmith; Diane K Reyes; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2006-03       Impact factor: 3.464

Review 4.  Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

Authors:  Riad Salem; Kenneth G Thurston
Journal:  J Vasc Interv Radiol       Date:  2006-08       Impact factor: 3.464

Review 5.  Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

Authors:  Bassel Atassi; Affaan K Bangash; Ammar Bahrani; Giuseppi Pizzi; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Vanessa L Gates; Mary F Mulcahy; Laura Kulik; Frank Miller; Vahid Yaghmai; Ravi Murthy; Andrew Larson; Reed A Omary; Riad Salem
Journal:  Radiographics       Date:  2008 Jan-Feb       Impact factor: 5.333

Review 6.  Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III.

Authors:  Robert H El-Maraghi; Elizabeth A Eisenhauer
Journal:  J Clin Oncol       Date:  2008-02-19       Impact factor: 44.544

Review 7.  Radiologic measurements of tumor response to treatment: practical approaches and limitations.

Authors:  Chikako Suzuki; Hans Jacobsson; Thomas Hatschek; Michael R Torkzad; Katarina Bodén; Yvonne Eriksson-Alm; Elisabeth Berg; Hirofumi Fujii; Atsushi Kubo; Lennart Blomqvist
Journal:  Radiographics       Date:  2008 Mar-Apr       Impact factor: 5.333

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

9.  Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation.

Authors:  Stephen J Hunt; Woojin Yu; Joshua Weintraub; Martin R Prince; Nishita Kothary
Journal:  J Vasc Interv Radiol       Date:  2008-11-22       Impact factor: 3.464

10.  Imaging response assessment in oncology.

Authors:  S D Curran; A U Muellner; L H Schwartz
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909
View more
  1 in total

1.  Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model.

Authors:  Tongqiang Li; Jiacheng Liu; Yingliang Wang; Chen Zhou; Qin Shi; Songjiang Huang; Chongtu Yang; Yang Chen; Yaowei Bai; Bin Xiong
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.